Mannatech (MTEX)
Market Price (5/24/2026): $4.43 | Market Cap: $8.5 MilSector: Consumer Staples | Industry: Food Distributors
Mannatech (MTEX)
Market Price (5/24/2026): $4.43Market Cap: $8.5 MilSector: Consumer StaplesIndustry: Food Distributors
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -45% Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. | Weak multi-year price returns2Y Excs Rtn is -86%, 3Y Excs Rtn is -145% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -7.5%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -8.5%, Rev Chg QQuarterly Revenue Change % is -6.2% Not cash flow generativeFCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.4% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -155% Key risksMTEX key risks include [1] declining distributor recruitment and retention, Show more. |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -45% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. |
| Weak multi-year price returns2Y Excs Rtn is -86%, 3Y Excs Rtn is -145% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -7.5%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -8.5%, Rev Chg QQuarterly Revenue Change % is -6.2% |
| Not cash flow generativeFCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.4% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -155% |
| Key risksMTEX key risks include [1] declining distributor recruitment and retention, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Mannatech (MTEX) stock has lost about 40% since 1/31/2026 because of the following key factors:
1. Persistent Decline in Net Sales: Mannatech continued to report declining revenue within the period. The company's net sales for the fourth quarter of 2025 were $26.6 million, an 8.2% decrease compared to the fourth quarter of 2024. This trend continued into the first quarter of 2026, with net sales reaching $24.9 million, a 6% year-over-year decrease, or 8.1% in constant currency, from Q1 2025.
2. Shrinking Associate and Customer Network: A significant reduction in Mannatech's independent associate and preferred customer base, coupled with declining recruitment, indicated ongoing challenges to its core direct-selling business model. As of March 31, 2026, the company reported approximately 111,000 independent associate and preferred customer positions, a decline from 129,000 a year earlier. Furthermore, the recruitment of new associates and preferred customers decreased by 15.6% in the first quarter of 2026 compared to the same period in 2025.
Show more
1. Persistent Decline in Net Sales: Mannatech continued to report declining revenue within the period. The company's net sales for the fourth quarter of 2025 were $26.6 million, an 8.2% decrease compared to the fourth quarter of 2024. This trend continued into the first quarter of 2026, with net sales reaching $24.9 million, a 6% year-over-year decrease, or 8.1% in constant currency, from Q1 2025.
2. Shrinking Associate and Customer Network: A significant reduction in Mannatech's independent associate and preferred customer base, coupled with declining recruitment, indicated ongoing challenges to its core direct-selling business model. As of March 31, 2026, the company reported approximately 111,000 independent associate and preferred customer positions, a decline from 129,000 a year earlier. Furthermore, the recruitment of new associates and preferred customers decreased by 15.6% in the first quarter of 2026 compared to the same period in 2025.
Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The -41.3% change in MTEX stock from 1/31/2026 to 5/23/2026 was primarily driven by a -38.2% change in the company's P/S Multiple.| (LTM values as of) | 1312026 | 5232026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.45 | 4.37 | -41.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 110 | 106 | -3.6% |
| P/S Multiple | 0.1 | 0.1 | -38.2% |
| Shares Outstanding (Mil) | 2 | 2 | -1.5% |
| Cumulative Contribution | -41.3% |
Market Drivers
1/31/2026 to 5/23/2026| Return | Correlation | |
|---|---|---|
| MTEX | -41.3% | |
| Market (SPY) | 8.1% | -5.1% |
| Sector (XLP) | 2.1% | -5.9% |
Fundamental Drivers
The -57.1% change in MTEX stock from 10/31/2025 to 5/23/2026 was primarily driven by a -53.8% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 5232026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.19 | 4.37 | -57.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 113 | 106 | -5.8% |
| P/S Multiple | 0.2 | 0.1 | -53.8% |
| Shares Outstanding (Mil) | 2 | 2 | -1.5% |
| Cumulative Contribution | -57.1% |
Market Drivers
10/31/2025 to 5/23/2026| Return | Correlation | |
|---|---|---|
| MTEX | -57.1% | |
| Market (SPY) | 9.9% | -1.8% |
| Sector (XLP) | 12.7% | -1.5% |
Fundamental Drivers
The -58.2% change in MTEX stock from 4/30/2025 to 5/23/2026 was primarily driven by a -52.6% change in the company's P/S Multiple.| (LTM values as of) | 4302025 | 5232026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.45 | 4.37 | -58.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 118 | 106 | -9.7% |
| P/S Multiple | 0.2 | 0.1 | -52.6% |
| Shares Outstanding (Mil) | 2 | 2 | -2.3% |
| Cumulative Contribution | -58.2% |
Market Drivers
4/30/2025 to 5/23/2026| Return | Correlation | |
|---|---|---|
| MTEX | -58.2% | |
| Market (SPY) | 36.0% | 3.3% |
| Sector (XLP) | 6.5% | -1.9% |
Fundamental Drivers
The -64.8% change in MTEX stock from 4/30/2023 to 5/23/2026 was primarily driven by a -52.8% change in the company's P/S Multiple.| (LTM values as of) | 4302023 | 5232026 | Change |
|---|---|---|---|
| Stock Price ($) | 12.40 | 4.37 | -64.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 137 | 106 | -22.5% |
| P/S Multiple | 0.2 | 0.1 | -52.8% |
| Shares Outstanding (Mil) | 2 | 2 | -3.8% |
| Cumulative Contribution | -64.8% |
Market Drivers
4/30/2023 to 5/23/2026| Return | Correlation | |
|---|---|---|
| MTEX | -64.8% | |
| Market (SPY) | 86.3% | 4.8% |
| Sector (XLP) | 18.8% | -0.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MTEX Return | 120% | -52% | -54% | 66% | -39% | -46% | -73% |
| Peers Return | 10% | -44% | 4% | -48% | 20% | -5% | -62% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 9% | 98% |
Monthly Win Rates [3] | |||||||
| MTEX Win Rate | 50% | 50% | 42% | 67% | 33% | 20% | |
| Peers Win Rate | 60% | 30% | 50% | 37% | 40% | 52% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| MTEX Max Drawdown | -43% | -60% | -59% | -31% | -52% | -57% | |
| Peers Max Drawdown | -33% | -55% | -43% | -57% | -36% | -32% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: HLF, NUS, USNA, NATR, MED.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/22/2026 (YTD)
How Low Can It Go
| Event | MTEX | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -29.3% | -18.8% |
| % Gain to Breakeven | 41.5% | 23.1% |
| Time to Breakeven | 22 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -28.6% | -9.5% |
| % Gain to Breakeven | 40.1% | 10.5% |
| Time to Breakeven | 363 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -57.9% | -33.7% |
| % Gain to Breakeven | 137.5% | 50.9% |
| Time to Breakeven | 71 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -19.9% | -19.2% |
| % Gain to Breakeven | 24.9% | 23.8% |
| Time to Breakeven | 33 days | 105 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -26.8% | -3.7% |
| % Gain to Breakeven | 36.7% | 3.9% |
| Time to Breakeven | 327 days | 6 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -12.5% | -12.2% |
| % Gain to Breakeven | 14.3% | 13.9% |
| Time to Breakeven | 44 days | 62 days |
In The Past
Mannatech's stock fell -29.3% during the 2025 US Tariff Shock. Such a loss loss requires a 41.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | MTEX | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -29.3% | -18.8% |
| % Gain to Breakeven | 41.5% | 23.1% |
| Time to Breakeven | 22 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -28.6% | -9.5% |
| % Gain to Breakeven | 40.1% | 10.5% |
| Time to Breakeven | 363 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -57.9% | -33.7% |
| % Gain to Breakeven | 137.5% | 50.9% |
| Time to Breakeven | 71 days | 140 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -26.8% | -3.7% |
| % Gain to Breakeven | 36.7% | 3.9% |
| Time to Breakeven | 327 days | 6 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -49.5% | -17.9% |
| % Gain to Breakeven | 97.9% | 21.8% |
| Time to Breakeven | 589 days | 123 days |
| 2010 Eurozone Sovereign Debt Crisis / Flash Crash | ||
| % Loss | -54.2% | -15.4% |
| % Gain to Breakeven | 118.5% | 18.2% |
| Time to Breakeven | 4047 days | 125 days |
In The Past
Mannatech's stock fell -29.3% during the 2025 US Tariff Shock. Such a loss loss requires a 41.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Mannatech (MTEX)
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
AI Analysis | Feedback
Here are a couple of analogies for Mannatech:
- Like Herbalife for advanced nutritional supplements and weight management, sold through network marketing.
- Like Nu Skin for a broader range of health and wellness products, including anti-aging skincare.
AI Analysis | Feedback
- Nutritional Supplements: Products designed to supplement the diet with vitamins, minerals, herbs, or other beneficial substances.
- Topical and Skin Care, and Anti-Aging Products: Products applied to the skin for beauty, health, or to reduce the visible signs of aging.
- Weight-Management Products: Products intended to assist individuals in controlling or maintaining their weight.
AI Analysis | Feedback
Major Customers of Mannatech (MTEX)
Mannatech (MTEX) primarily sells its products directly to individuals through e-commerce and network marketing channels. Therefore, its major customers are categories of individual consumers rather than other companies. The primary customer categories are:
- Independent Associates/Distributors: Individuals who purchase Mannatech products for personal consumption, and also to resell to their own customer base as part of the company's network marketing model. These associates are a critical sales channel and a significant direct customer segment.
- End Consumers Seeking Nutritional Support: Individuals who purchase nutritional supplements directly from Mannatech or its associates to support their general health, well-being, energy levels, or specific dietary needs.
- End Consumers Focused on Beauty, Anti-Aging, and Weight Management: Individuals who purchase Mannatech's topical and skin care, anti-aging products, and weight-management products for cosmetic purposes, to support a healthy appearance, or to achieve weight-related goals.
AI Analysis | Feedback
nullAI Analysis | Feedback
Landen Fredrick, President and Chief Executive Officer
Landen Fredrick was appointed President and Chief Executive Officer of Mannatech, Incorporated on April 1, 2024. He joined Mannatech in 2006 and previously served as President and Chief Operating Officer from June 2023. Prior to his tenure at Mannatech, he owned a web and advertising business, Killian Fredrick, from 2001 to 2006. Mr. Fredrick also serves as the Chairman of the M5M Foundation.
James Clavijo, Chief Financial Officer and Principal Accounting Officer
James Clavijo was appointed Chief Financial Officer of Mannatech, Incorporated, effective July 1, 2024. He brings over 25 years of experience in executive, finance, and accounting activities. Mr. Clavijo has served as CFO for various biotech, medical technology, and pharmaceutical companies, including Longeveron, Guided Therapeutics, Aeterna Zentaris, and Tri-source Pharma. His experience includes leading and advising companies on strategic plans for pharmaceutical commercialization and manufacturing, negotiating licensing and drug development agreements, and advising on complex restructurings, mergers, acquisitions, and capital market transactions. Additionally, he served as an Officer in the U.S. Army for 13 years in active and reserve duty.
J. Stanley Fredrick, Chairman of the Board
J. Stanley Fredrick has served on Mannatech's Board of Directors since 2001 and as Chairman since 2009.
Robert A. Toth, Vice Chairman of the Board
Robert A. Toth was appointed Vice Chairman of the Board of Directors for Mannatech, Incorporated, effective December 1, 2024. He previously served on the company's Board from March 2008 through May 31, 2023. Mr. Toth has over 40 years of experience in direct selling, including serving as President of Avon International from 2004 to 2005, where his operations spanned over 120 countries with annual revenues exceeding $5.5 billion. He was also the co-founder and Chairman of Tatra Spring LLC, a supply chain services company based in Poland, until May 2015.
Erin Barta, General Counsel and Corporate Secretary
Erin Barta joined Mannatech in 2006. She was named General Counsel and Corporate Secretary in August 2013, having previously served as Senior Corporate Counsel and Assistant General Counsel. Before joining Mannatech, Ms. Barta served as Corporate Counsel and Senior Corporate Counsel for Metromedia Restaurant Group.
AI Analysis | Feedback
The key risks to Mannatech's business include:- Regulatory and Legal Scrutiny: Mannatech has a history of regulatory issues, including past settlements with the Texas Attorney General for deceptive marketing practices and unapproved health claims regarding its products. The company's direct selling model is subject to ongoing regulatory oversight concerning pyramid schemes and compensation plans. Additionally, the Direct Selling Self-Regulatory Council (DSSRC) has inquired into earnings claims made by the company and its salesforce, leading to requests for content modification or discontinuation. The U.S. Food and Drug Administration (FDA) has also cited Mannatech for failing to comply with Current Good Manufacturing Practice (CGMP) regulations for dietary supplements, indicating issues with product preparation, packing, or holding conditions.
- Ability to Attract and Retain Independent Associates and Members: Mannatech's business model heavily relies on its global network of independent associates and preferred customers for product distribution and sales. The company's performance is significantly influenced by its ability to attract and retain these individuals. There has been a notable decline in the number of active "positions" (associates plus preferred customers), with a reported drop of approximately 27% from 183,000 in 2020 to 133,000 in 2024. This erosion of the associate base, coupled with increasing competition in its markets, poses a substantial risk to sustained growth.
- Declining Financial Performance and Market Volatility: The company has experienced challenges in maintaining revenue growth and consistent profitability. Net revenue decreased from $151.4 million in 2020 to $117.9 million in 2024, with reported net losses in some years. Mannatech has faced sales declines and notes the inherent volatility of international markets, particularly in Asia/Pacific, as key factors impacting sales and recruitment efforts. Furthermore, supply chain disruptions and increased freight costs have contributed to a decrease in gross profit margins.
AI Analysis | Feedback
<p>The primary emerging threat to Mannatech stems from a significant shift in consumer preferences and market dynamics for health and wellness products.</p>
<p><strong>Decline in appeal and trust for the network marketing (multi-level marketing) model:</strong> Mannatech heavily relies on direct sales and network marketing channels. There is a clear trend, particularly among younger demographics, of increasing skepticism and distrust towards traditional multi-level marketing (MLM) structures. Consumers are increasingly wary of business models perceived as prioritizing recruitment over genuine product sales, and concerns regarding product efficacy, pricing transparency, and the potential for predatory practices associated with MLMs continue to grow. This eroding trust directly threatens Mannatech's core sales channel and its ability to attract and retain independent distributors and customers.</p>
<p><strong>Rise of agile, digitally-native, direct-to-consumer (DTC) health and wellness brands:</strong> A growing number of new competitors are emerging in the health and wellness space. These brands leverage advanced digital marketing, social media influence, and direct-to-consumer e-commerce models. They often offer products with strong brand narratives, greater transparency in sourcing and ingredients, and can adapt quickly to market trends, sometimes offering personalized nutrition solutions. These DTC brands bypass the overhead and complexities of a network marketing structure, potentially offering more competitive pricing or a more appealing, modern shopping experience, directly challenging Mannatech's product offerings and e-commerce channel by presenting a fundamentally different and often preferred purchasing paradigm for contemporary consumers.</p>AI Analysis | Feedback
The addressable markets for Mannatech's main products and services are substantial, both globally and within the United States.
Nutritional Supplements
- Globally, the nutritional supplements market was estimated at USD 517.09 billion in 2025 and is projected to reach USD 862.51 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 6.62% from 2026 to 2033.
- In the U.S., the dietary supplements market was valued at USD 70 billion in 2025 and is projected to expand to USD 128 billion by 2033, at a CAGR of 7.80% from 2026 to 2033.
Topical, Skin Care, and Anti-Aging Products
- The global skincare market size was calculated at USD 178.63 billion in 2025 and is predicted to increase to approximately USD 340.25 billion by 2035, with a CAGR of 6.66% from 2026 to 2035.
- Within the U.S., the skin care products market size reached USD 42,781.4 million in 2025 and is projected to reach USD 60,838.7 million by 2034, exhibiting a CAGR of 3.99% during 2026-2034.
- For anti-aging products specifically, the global market was valued at USD 85.13 billion in 2025 and is estimated to grow to USD 127.63 billion by 2031, at a CAGR of 6.99% during the forecast period (2026-2031).
- The U.S. anti-aging market size was calculated at US$ 21.61 billion in 2025 and is projected to reach around US$ 39.6 billion by 2034, expanding at a CAGR of 6.95% between 2025 and 2034.
Weight-Management Products
- The global weight management market size reached USD 591.7 billion in 2025 and is expected to reach USD 906.0 billion by 2034, exhibiting a growth rate (CAGR) of 4.80% during 2026-2034.
- In the United States, the weight management market size was valued at USD 87.00 billion in 2025 and is projected to reach USD 132.87 billion by 2034, growing at a CAGR of 4.99% from 2026-2034.
- Focusing on weight loss supplements, the global market size was valued at USD 31.60 billion in 2025 and is projected to grow from USD 35.83 billion in 2026 to USD 100.24 billion by 2034, exhibiting a CAGR of 13.72% during the forecast period.
- The U.S. weight loss supplements market is projected to reach USD 17.23 billion by 2032.
AI Analysis | Feedback
For Mannatech (MTEX), expected drivers of future revenue growth over the next 2-3 years include:
- Expansion of Product Pipeline: Mannatech is actively pursuing growth by expanding its product pipeline. This strategy aims to introduce new nutritional supplements, topical and skin care, anti-aging, and weight-management products to attract new customers and increase sales from existing ones.
- Entering New Markets: The company is focused on entering new markets where there is increasing demand for nutritional products. This geographic expansion is intended to broaden its customer base and tap into previously unaddressed consumer segments.
- Growth in the Asia/Pacific Region: The Asia/Pacific region has been identified as a primary growth engine for Mannatech. Continued focus and success in this region are expected to contribute significantly to overall revenue, potentially offsetting challenges in other areas.
- Enhancement of Digital Platforms for Associate Training: Mannatech is working on improving its digital platforms for associate training. By empowering its independent associates through better training and resources, the company aims to increase their productivity and effectiveness in promoting and selling products, thereby driving sales growth through its network marketing channels.
- Strategic Price Adjustments: The company has demonstrated its ability to implement price increases, which contributed to an improved gross profit margin in Q3 2025. While primarily impacting profitability, the ability to strategically adjust selling prices can also serve as a driver for revenue growth, especially if accompanied by stable demand.
AI Analysis | Feedback
Share Repurchases
- During the year ended December 31, 2023, Mannatech repurchased 13,454 shares of its common stock at an average price of $13.06.
- In 2023, the Company repurchased $0.2 million in common stock.
- During the year ended December 31, 2022, Mannatech repurchased 99,293 shares of its common stock at an average price of $21.87.
Share Issuance
- As of February 29, 2024, the number of common shares outstanding was 1,884,814.
- As of December 31, 2023, Mannatech had 2,742,857 shares issued and 1,860,154 shares outstanding.
- As of December 31, 2022, the number of common shares outstanding was 1,858,800.
Capital Expenditures
- Mannatech invested $489K in capital expenditures in Q1 2025, primarily for funding long-term assets and infrastructure.
- For the nine months ended September 30, 2024, the acquisition of property and equipment was $0.4 million, a decrease from $0.5 million for the same period in 2023.
- In 2023, the company invested approximately $0.7 million in back-office software projects and equipment.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Mannatech Earnings Notes | 12/16/2025 | |
| Can Mannatech Stock Recover If Markets Fall? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to MTEX.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04102026 | ELF | e.l.f. Beauty | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.8% | -1.8% | -6.2% |
| 04022026 | IPAR | Interparfums | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.7% | 0.7% | -0.3% |
| 04022026 | COKE | Coca-Cola Consolidated | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 5.5% | 5.5% | -5.2% |
| 03272026 | MZTI | Marzetti | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.0% | -5.0% | -8.6% |
| 03272026 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.5% | -1.5% | -2.3% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 12.51 |
| Mkt Cap | 0.3 |
| Rev LTM | 708 |
| Op Inc LTM | 39 |
| FCF LTM | 13 |
| FCF 3Y Avg | 35 |
| CFO LTM | 24 |
| CFO 3Y Avg | 44 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -1.9% |
| Rev Chg 3Y Avg | -5.0% |
| Rev Chg Q | -3.0% |
| QoQ Delta Rev Chg LTM | -0.7% |
| Op Inc Chg LTM | 21.8% |
| Op Inc Chg 3Y Avg | -11.5% |
| Op Mgn LTM | 5.5% |
| Op Mgn 3Y Avg | 4.6% |
| QoQ Delta Op Mgn LTM | -0.0% |
| CFO/Rev LTM | 3.5% |
| CFO/Rev 3Y Avg | 6.0% |
| FCF/Rev LTM | 1.6% |
| FCF/Rev 3Y Avg | 4.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.3 |
| P/S | 0.3 |
| P/Op Inc | 5.3 |
| P/EBIT | 3.1 |
| P/E | 5.3 |
| P/CFO | 8.1 |
| Total Yield | 3.8% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 7.8% |
| D/E | 0.5 |
| Net D/E | -0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -12.8% |
| 3M Rtn | -25.1% |
| 6M Rtn | -0.6% |
| 12M Rtn | -11.2% |
| 3Y Rtn | -67.2% |
| 1M Excs Rtn | -18.0% |
| 3M Excs Rtn | -34.1% |
| 6M Excs Rtn | -7.4% |
| 12M Excs Rtn | -38.6% |
| 3Y Excs Rtn | -147.4% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Proprietary nutritional supplements, skin care and anti-aging products, and weight-management and | 118 | 132 | |||
| Other | 1 | 1 | 1 | ||
| Pack sales | 6 | 8 | 4 | ||
| Product sales | 130 | 151 | 146 | ||
| Total | 118 | 132 | 137 | 160 | 151 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Proprietary nutritional supplements, skin care and anti-aging products, and weight-management and | 2 | ||||
| Total | 2 |
Price Behavior
Price Behavior
| Market Price | $4.37 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 02/16/1999 | |
| Distance from 52W High | -60.0% | |
| 50 Days | 200 Days | |
| DMA Price | $6.11 | $8.35 |
| DMA Trend | down | down |
| Distance from DMA | -28.5% | -47.6% |
| 3M | 1YR | |
| Volatility | 101.1% | 90.8% |
| Downside Capture | 188.67 | 180.29 |
| Upside Capture | -63.38 | 27.89 |
| Correlation (SPY) | -6.8% | 4.5% |
MTEX Betas & Captures as of 4/30/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.95 | -1.00 | -0.63 | -0.25 | 0.14 | 0.19 |
| Up Beta | -2.73 | -2.26 | -1.97 | -1.79 | 0.49 | 0.26 |
| Down Beta | -10.29 | -1.90 | -1.41 | -1.08 | -1.41 | -0.06 |
| Up Capture | -124% | -117% | -80% | -22% | -8% | 1% |
| Bmk +ve Days | 15 | 22 | 31 | 66 | 141 | 428 |
| Stock +ve Days | 7 | 16 | 23 | 51 | 94 | 275 |
| Down Capture | 1220% | 83% | 116% | 130% | 116% | 75% |
| Bmk -ve Days | 4 | 18 | 30 | 56 | 108 | 321 |
| Stock -ve Days | 15 | 22 | 35 | 68 | 135 | 331 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MTEX | |
|---|---|---|---|---|
| MTEX | -55.7% | 91.0% | -0.60 | - |
| Sector ETF (XLP) | 6.8% | 12.4% | 0.25 | 2.7% |
| Equity (SPY) | 29.5% | 12.0% | 1.86 | 4.7% |
| Gold (GLD) | 35.5% | 26.8% | 1.11 | -4.2% |
| Commodities (DBC) | 42.9% | 18.7% | 1.77 | -10.2% |
| Real Estate (VNQ) | 15.2% | 13.1% | 0.82 | 3.0% |
| Bitcoin (BTCUSD) | -31.3% | 41.8% | -0.78 | 3.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MTEX | |
|---|---|---|---|---|
| MTEX | -8.6% | 80.5% | 0.20 | - |
| Sector ETF (XLP) | 6.4% | 13.2% | 0.27 | 3.9% |
| Equity (SPY) | 14.0% | 17.0% | 0.64 | 5.7% |
| Gold (GLD) | 18.8% | 18.0% | 0.85 | 1.6% |
| Commodities (DBC) | 10.4% | 19.4% | 0.42 | 0.5% |
| Real Estate (VNQ) | 3.8% | 18.8% | 0.10 | 4.0% |
| Bitcoin (BTCUSD) | 11.6% | 55.3% | 0.41 | 1.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MTEX | |
|---|---|---|---|---|
| MTEX | -2.1% | 67.3% | 0.25 | - |
| Sector ETF (XLP) | 7.6% | 14.7% | 0.38 | 4.2% |
| Equity (SPY) | 15.7% | 17.9% | 0.75 | 10.6% |
| Gold (GLD) | 13.0% | 16.0% | 0.67 | 3.3% |
| Commodities (DBC) | 7.8% | 17.9% | 0.35 | 3.8% |
| Real Estate (VNQ) | 5.5% | 20.7% | 0.23 | 9.0% |
| Bitcoin (BTCUSD) | 66.7% | 66.9% | 1.06 | 1.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/15/2026 | 6.9% | -5.2% | -6.9% |
| 11/12/2025 | 0.1% | -0.5% | -12.2% |
| 11/12/2024 | 6.7% | 7.3% | 57.1% |
| 8/13/2024 | -1.9% | -1.1% | 7.8% |
| 5/14/2024 | 7.4% | 7.4% | 7.8% |
| 11/7/2023 | 0.0% | -3.6% | -4.3% |
| 8/14/2023 | -6.3% | -15.4% | -25.4% |
| 3/7/2023 | 0.0% | 6.5% | 0.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 10 | 8 | 9 |
| # Negative | 6 | 8 | 7 |
| Median Positive | 1.7% | 5.9% | 7.8% |
| Median Negative | -3.4% | -2.6% | -6.8% |
| Max Positive | 7.4% | 32.5% | 57.1% |
| Max Negative | -6.3% | -15.4% | -25.4% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 04/15/2026 | 10-K |
| 09/30/2025 | 11/12/2025 | 10-Q |
| 06/30/2025 | 08/12/2025 | 10-Q |
| 03/31/2025 | 05/13/2025 | 10-Q |
| 12/31/2024 | 03/26/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/13/2024 | 10-Q |
| 03/31/2024 | 05/14/2024 | 10-Q |
| 12/31/2023 | 03/28/2024 | 10-K |
| 09/30/2023 | 11/07/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/12/2023 | 10-Q |
| 12/31/2022 | 03/17/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/12/2022 | 10-Q |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.